KCTD4 Antibodies

Santa Cruz Biotechnology delivers a wide array of KCTD4 monoclonal antibodies for research applications. KCTD4 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KCTD4, or Potassium Channel Tetramerization Domain Containing 4, plays a critical role in cellular processes, including the regulation of ion channels and modulation of signaling pathways. Research has shown KCTD4's significant involvement in neuronal function, with potential implications across various diseases. Understanding KCTD4's molecular mechanisms and interactions can reveal new therapeutic targets and treatment strategies. Investigating KCTD4's role in cellular signaling networks continues to yield valuable insights into both normal physiology and pathological conditions. Current research focuses on understanding how KCTD4 influences ion channel assembly and function in different cellular environments. Ongoing studies are uncovering new aspects of KCTD4's involvement in neurological disorders and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of KCTD4's role in health and disease.